The Dow trimmed a larger rise to 0.3% at midday Tuesday, as Nvidia stock slashed its increase to 0.6% from a gain of more ...

Wall Street firm Jefferies believes certain biotechnology stocks are poised to benefit from AI advancements. Analyst Michael Yee told CNBC that the sector is likely to save billions of dollars as well ...

Akari Therapeutics is an oncology biotechnology company developing next-generation spliceosome payload antibody drug conjugates (ADCs). Utilizing its innovative ADC discovery platform, the Company has ...

Exchange-traded funds that track companies in the biotechnology industry were surging on Tuesday afternoon as large-cap stocks lost ground and investors turned to small-cap names. The SPDR S&P Biotech ...

Tyra Biosciences, Inc. (Nasdaq: TYRA) is a clinical-stage biotechnology company focused on developing next-generation precision medicines that target large opportunities in FGFR biology. The Company's ...

The event will focus on UNITY’s ongoing Phase 2b ASPIRE study evaluating foselutoclax (UBX1325) head-to-head against aflibercept in diabetic macular edema (DME). Twenty-four-week safety and efficacy ...

The market for pneumonia vaccines is dominated by big pharma. Pfizer’s pneumococcal vaccine, Prevnar, raked in $6.4 billion in revenue last year. Merck has introduced a strong competitor. Now, a ...